{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:29:52Z","timestamp":1792056592591,"version":"4.4.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012235","name":"Aeglea BioTherapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110205","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:10:46Z","timestamp":1784589046000},"page":"110205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between elevated arginine and pathophysiology of progressive disease in arginase 1 deficiency"],"prefix":"10.1016","volume":"149","author":[{"given":"Mattias","family":"Rudebeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Batzios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3476(77)80368-5","article-title":"Hyperargininemia","volume":"90","author":"Cederbaum","year":"1977","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110205_bb0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1203\/00006450-197907000-00007","article-title":"Hyperargininemia with arginase deficiency","volume":"13","author":"Cederbaum","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110205_bb0015","series-title":"Arginase Deficiency. University of Washington, Seattle","author":"Sun","year":"2020"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0020","first-page":"101","article-title":"Hyperargininemia, epilepsy and the metabolism of guanidino compounds","volume":"28","author":"Wiechert","year":"1989","journal-title":"Padiatr. Grenzgeb."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2004.11.004","article-title":"Hyperargininemia due to liver arginase deficiency","volume":"84","author":"Crombez","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2022.08.005","article-title":"Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): a systematic review","volume":"137","author":"Bin Sawad","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110205_bb0035","first-page":"427","article-title":"Guanidino compounds in hyperargininemia","author":"Marescau","year":"1992","journal-title":"In"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1525-139X.2009.00577.x","article-title":"Guanidino compounds as uremic (neuro)toxins","volume":"22","author":"De Deyn","year":"2009","journal-title":"Semin. Dial."},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2026.110205_bb0045","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0050","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/ped.14945","article-title":"Case series of arginase 1 deficiency: expanding the spectrum in hyperargininemia","volume":"64","author":"Dorum","year":"2022","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2026.110205_bb0060","article-title":"Retrospective analysis of arginase 1 deficiency progression in adults over 5years at a single metabolic Centre","author":"Sharma","year":"2024","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2052-0492-2-22","article-title":"Hyperammonemia due to urea cycle disorders: a potentially fatal condition in the intensive care setting","volume":"2","author":"Machado","year":"2014","journal-title":"J. Intensive Care"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jimd.12564","article-title":"The role and control of arginine levels in arginase 1 deficiency","volume":"46","author":"Diaz","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0920-1211(91)90081-P","article-title":"Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture","volume":"8","author":"De Deyn","year":"1991","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0080","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jimd.12343","article-title":"Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency","volume":"44","author":"Diaz","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110205_bb0085","article-title":"Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-Centre trial","volume":"68","author":"Sanchez Russo","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110205_bb0090","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1440-1681.2007.04638.x","article-title":"Arginase: a critical regulator of nitric oxide synthesis and vascular function","volume":"34","author":"Durante","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110205_bb0095","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3390\/nu13082498","article-title":"The effect of amino acids on wound healing: a systematic review and meta-analysis on arginine and glutamine","volume":"13","author":"Arribas-L\u00f3pez","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2026.110205_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.773866","article-title":"Arginase Signalling as a key player in chronic wound pathophysiology and healing","volume":"8","author":"Szondi","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"13","key":"10.1016\/j.ymgme.2026.110205_bb0105","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1007\/s00018-021-03828-4","article-title":"Arginine-dependent immune responses","volume":"78","author":"Mart\u00ed i L\u00edndez","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110205_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/10408398.2011.573885","article-title":"L-arginine and nitric oxide in CNS function and neurodegenerative diseases","volume":"53","author":"Virarkar","year":"2013","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0115","doi-asserted-by":"crossref","first-page":"2579S","DOI":"10.3945\/jn.115.226621","article-title":"Arginine metabolism revisited","volume":"146","author":"Morris","year":"2016","journal-title":"J. Nutr."},{"issue":"D1","key":"10.1016\/j.ymgme.2026.110205_bb0120","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1042\/bj3490787","article-title":"The heterodimeric amino acid transporter 4F2hc\/y+LAT2 mediates arginine efflux in exchange with glutamine","volume":"349","author":"Br\u00f6er","year":"2000","journal-title":"Biochem. J."},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2026.110205_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-4157(85)90015-2","article-title":"The transport of cationic amino acids across the plasma membrane of mammalian cells","volume":"822","author":"White","year":"1985","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0135","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3945\/jn.111.148197","article-title":"Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the framingham offspring cohort","volume":"141","author":"L\u00fcneburg","year":"2011","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1203\/00006450-199003000-00020","article-title":"Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of Guanidino compound levels during therapy","volume":"27","author":"Marescau","year":"1990","journal-title":"Pediatr. Res."},{"issue":"S1","key":"10.1016\/j.ymgme.2026.110205_bb0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1023\/A:1005313809037","article-title":"The human arginases and arginase deficiency","volume":"21","author":"Iyer","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0150","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/BF02533103","article-title":"The characteristics of arginine transport by rat cerebellar and cortical synaptosomes","volume":"21","author":"Aldridge","year":"1996","journal-title":"Neurochem. Res."},{"issue":"22","key":"10.1016\/j.ymgme.2026.110205_bb0155","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1093\/hmg\/ddv352","article-title":"Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency","volume":"24","author":"Burrage","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.ymgme.2026.110205_bb0160","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1128\/MCB.22.13.4491-4498.2002","article-title":"Mouse model for human arginase deficiency","volume":"22","author":"Iyer","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0165","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0026-0495(95)90114-0","article-title":"Guanidino compounds in serum and urine of cirrhotic patients","volume":"44","author":"Marescau","year":"1995","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ymgme.2026.110205_bb0170","doi-asserted-by":"crossref","first-page":"PL131","DOI":"10.1016\/S0024-3205(96)80013-0","article-title":"The effects of arginine administration on the levels of arginine, other amino acids and related amino compounds in the plasma, heart, aorta, vena cava, bronchi and pancreas of the rat","volume":"58","author":"Noeh","year":"1996","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0175","first-page":"133","article-title":"Effect of arginine administration on plasma and brain levels of arginine and various related amino compounds in the rat","volume":"53","author":"Buchmann","year":"1996","journal-title":"Pharmacology"},{"key":"10.1016\/j.ymgme.2026.110205_bb0180","series-title":"Nitric Oxide in Health and Disease. First ed Biomedical Research Topics","author":"Lincoln","year":"1997"},{"issue":"8","key":"10.1016\/j.ymgme.2026.110205_bb0185","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/NEN.0b013e3181ea5203","article-title":"Nitric oxide plays a key role in myelination in the developing brain","volume":"69","author":"Olivier","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0190","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2011.09.112","article-title":"Intracellular l-arginine concentration does not determine NO production in endothelial cells: implications on the \u201cl-arginine paradox\u201d","volume":"414","author":"Shin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbamcr.2004.12.006","article-title":"Y+ and y+L arginine transporters in neuronal cells expressing tyrosine hydroxylase","volume":"1745","author":"Bae","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110205_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF03401756","article-title":"High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells","volume":"4","author":"Todoroki","year":"1998","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(03)03370-5","article-title":"Pharmacokinetics and pharmacodynamics of l-arginine in rats: a model of stimulated neuronal nitric oxide synthesis","volume":"989","author":"Heinzen","year":"2003","journal-title":"Brain Res."},{"issue":"6438","key":"10.1016\/j.ymgme.2026.110205_bb0215","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/364584a0","article-title":"ALS, SOD and peroxynitrite","volume":"364","author":"Beckman","year":"1993","journal-title":"Nature"},{"issue":"6438","key":"10.1016\/j.ymgme.2026.110205_bb0220","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0005-2728(98)00168-6","article-title":"Nitric oxide, mitochondria and neurological disease","volume":"1410","author":"Heales","year":"1999","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2026.110205_bb0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity","volume":"10","author":"Dawson","year":"1996","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ymgme.2026.110205_bb0235","series-title":"Guanidino Compounds in Biology and Medicine","first-page":"57","article-title":"A role for guanidino compounds in the brain","author":"Hiramatsu","year":"2003"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/jphysiol.1997.sp021949","article-title":"Renal handling of guanidino compounds in rat and rabbit","volume":"499","author":"Levillain","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymgme.2026.110205_bb0245","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ymgme.2010.01.012","article-title":"Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia","volume":"100","author":"Deignan","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2007.09.016","article-title":"Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia","volume":"93","author":"Deignan","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110205_bb0255","series-title":"The Fourth International Symposium on Guanidino Compounds in Biology and Medicine","first-page":"450","article-title":"Guanidino compounds in biology and medicine ii","author":"De Deyn","year":"1997"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/nu14010075","article-title":"Safety of dietary Guanidinoacetic acid: a villain of a good guy?","volume":"14","author":"Ostojic","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110205_bb0265","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00726-015-1960-y","article-title":"Possible sources and functions of l-homoarginine in the brain: review of the literature and own findings","volume":"47","author":"Bernstein","year":"2015","journal-title":"Amino Acids"},{"issue":"10","key":"10.1016\/j.ymgme.2026.110205_bb0270","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/jn\/131.10.2732","article-title":"Overexpression of arginase alters circulating and tissue amino acids and Guanidino compounds and affects Neuromotor behavior in mice","volume":"131","author":"de Jonge","year":"2001","journal-title":"J. Nutr."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110205_bb0275","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/gt.2012.99","article-title":"AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse","volume":"20","author":"Lee","year":"2013","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-8981(85)90120-2","article-title":"Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy","volume":"146","author":"Marescaua","year":"1985","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0285","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/children13050610","article-title":"Pegzilarginase in arginase 1 deficiency: clinical and biochemical effects of treatment initiation, discontinuation and re-initiation","volume":"13","author":"Faraguna","year":"2026","journal-title":"Children"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2006.04.007","article-title":"Ornithine deficiency in the arginase double knockout mouse","volume":"89","author":"Deignan","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.06.025","article-title":"Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?","volume":"104","author":"Jain-Ghai","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0300","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1023\/A:1021647329937","article-title":"Inhibition of na(+),k(+)-atpase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins e and c treatment","volume":"27","author":"Wyse","year":"2002","journal-title":"Neurochem. Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0006-8993(99)01671-6","article-title":"In vitro inhibition of Na+,K+-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia","volume":"838","author":"da Silva","year":"1999","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0310","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1010912929042","article-title":"Nitric oxide synthase inhibition by l-name prevents the decrease of na+,k+-atpase activity in midbrain of rats subjected to arginine administration","volume":"26","author":"Wyse","year":"2001","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0315","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(02)03077-9","article-title":"Arginine administration inhibits hippocampal Na+,K+-ATPase activity and impairs retention of an inhibitory avoidance task in rats","volume":"951","author":"dos Reis","year":"2002","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(03)03029-4","article-title":"Reduction of energy metabolism in rat hippocampus by arginine administration","volume":"983","author":"Delwing","year":"2003","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11011-007-9053-6","article-title":"Inhibition of CO2 production from glucose by arginine in brain slices of rats","volume":"22","author":"Delwing","year":"2007","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0736-5748(02)00138-7","article-title":"In vitro effects of L-arginine and guanidino compounds on NTPDase1 and 5\u2032-nucleotidase activities from rat brain synaptosomes","volume":"21","author":"Balz","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110205_bb0335","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11064-007-9292-2","article-title":"NTPDase and 5\u2032-nucleotidase activities of Synaptosomes from Hippocampus of rats subjected to hyperargininemia","volume":"32","author":"Delwing","year":"2007","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/15216549600201622","article-title":"Guanidino compounds generate reactive oxygen species","volume":"40","author":"Mori","year":"1996","journal-title":"IUBMB Life"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0345","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3045","article-title":"Effect of N-acetylarginine, a metabolite accumulated in hyperargininemia, on parameters of oxidative stress in rats: protective role of vitamins and L-NAME","volume":"32","author":"Sasso","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0350","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/088307389701200502","article-title":"Argininemia: a treatable genetic cause of progressive spastic Diplegia simulating cerebral palsy: case reports and literature review","volume":"12","author":"Prasad","year":"1997","journal-title":"J. Child Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11011-006-9028-z","article-title":"Arginine administration reduces creatine kinase activity in rat cerebellum","volume":"22","author":"Delwing","year":"2007","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2026.110205_bb0360","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0365","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.171.3.1232","article-title":"L-arginine consumption by macrophages modulates the expression of CD3\u03b6 chain in T lymphocytes","volume":"171","author":"Rodriguez","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0370","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: an emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.ymgme.2026.110205_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130260","article-title":"Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2026.110205_bb0380","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2011.03.038","article-title":"Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation","volume":"1392","author":"Kouhsar","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2026.110205_bb0385","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a006232","article-title":"Arginase 1 deficiency presenting as complicated hereditary spastic paraplegia","author":"Freua","year":"2022","journal-title":"Mol. Case Stud."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/revneuro-2017-0033","article-title":"Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes","volume":"29","author":"Lan","year":"2017","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13023-014-0197-2","article-title":"Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review","volume":"9","author":"Leach","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mdc3.13612","article-title":"Arginase 1 deficiency in patients initially diagnosed with hereditary spastic paraplegia","volume":"10","author":"McNutt","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110205_bb0405","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s10072-025-08153-3","article-title":"Arginase 1 deficiency: a treatable form of spastic paraplegia","volume":"46","author":"Burlina","year":"2025","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13023-019-1181-7","article-title":"Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia","volume":"14","author":"Olivieri","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110205_bb0415","article-title":"Nitric oxide, iron and neurodegeneration","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"25","key":"10.1016\/j.ymgme.2026.110205_bb0420","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1523\/JNEUROSCI.0897-16.2016","article-title":"Rescue of the functional alterations of motor cortical circuits in arginase deficiency by neonatal gene therapy","volume":"36","author":"Cantero","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2026.110205_bb0425","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.omtn.2022.04.012","article-title":"Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency","volume":"28","author":"Khoja","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.braindev.2010.03.001","article-title":"A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations","volume":"33","author":"Segawa","year":"2011","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0435","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1552-6569.2007.00217.x","article-title":"Neuroimaging findings in hyperargininemia","volume":"18","author":"G\u00fcng\u00f6r","year":"2008","journal-title":"J. Neuroimaging"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0440","first-page":"1198","article-title":"Early administration of l-arginine in experimental acute spinal cord injury impairs long-term motor function recovery","volume":"70","author":"Esquivel-Aguilar","year":"2011","journal-title":"J. Trauma"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0445","doi-asserted-by":"crossref","first-page":"20490","DOI":"10.1038\/s41598-020-77526-9","article-title":"Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington\u2019s disease for participants of varying functional disability: a pilot study","volume":"10","author":"McGarry","year":"2020","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.ymgme.2026.110205_bb0450","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Miljkovi\u0107","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0455","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.0022-3042.2002.00744.x","article-title":"Generation of reactive oxygen species by the mitochondrial electron transport chain","volume":"80","author":"Liu","year":"2002","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0460","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/mgme.2001.3257","article-title":"Improving treatment of Guanidinoacetate methyltransferase deficiency: reduction of Guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation","volume":"74","author":"Schulze","year":"2001","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0465","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3940(99)00190-1","article-title":"Uraemic guanidino compounds inhibit \u03b3 -aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones","volume":"265","author":"D\u2019Hooge","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0470","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/15216549600201091","article-title":"Seizures induced by \u03b1-guanidinoglutaric acid, a nitric oxide synthase inhibitor, are controlled by l-arginine","volume":"39","author":"Habu","year":"1996","journal-title":"IUBMB Life"},{"issue":"5062","key":"10.1016\/j.ymgme.2026.110205_bb0475","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/212617a0","article-title":"\u03b3-Guanidinobutyric acid as a convulsive substance","volume":"212","author":"Jinnai","year":"1966","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0480","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1528-1157.1991.tb05531.x","article-title":"Increase of Methylguanidine and Guanidinoacetic acid in the brain of amygdala-kindled rats","volume":"32","author":"Hirayasu","year":"1991","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0485","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1528-1157.1985.tb05705.x","article-title":"Altered amino acid levels in multiply affected Sibships with seizures","volume":"26","author":"Haines","year":"1985","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0490","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410280505","article-title":"Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture","volume":"28","author":"De Deyn","year":"1990","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110205_bb0495","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(88)91023-2","article-title":"Effects of \u03b1-keto-\u03b4-guanidinovaleric acid on inhibitory amino acid responses on mouse neurons in cell culture","volume":"449","author":"De Deyn","year":"1988","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0500","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0920-1211(87)90016-7","article-title":"\u0394-Guanidinovaleric acid as an endogenous and specific GABA-receptor antagonist: electroencephalographic study","volume":"1","author":"Yokoi","year":"1987","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0505","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2478\/acph-2018-0022","article-title":"Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels","volume":"68","author":"Vega Rasgado","year":"2018","journal-title":"Acta Pharma."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0510","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0304-3940(94)90529-0","article-title":"Modulation by nitric oxide of rat brain GABAA receptors","volume":"180","author":"Zarri","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"S1","key":"10.1016\/j.ymgme.2026.110205_bb0515","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/ana.410160719","article-title":"Glial and neuronal Na+-K+ pump in epilepsy","volume":"16","author":"Grisar","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2026.110205_bb0520","series-title":"Guanidino Compounds in Biology and Medicine","first-page":"387","article-title":"Effect of guanidino compounds on membrane fluidity of rat synaptosomes","author":"Hiramatsu","year":"1992"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0525","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1023254822094","article-title":"Brain Na+,K+-ATPase inhibition induced by arginine administration is prevented by vitamins E and C","volume":"28","author":"Bavaresco","year":"2003","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11011-006-9003-8","article-title":"Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and Creatine kinase activities in rat striatum","volume":"21","author":"Zugno","year":"2006","journal-title":"Metab. Brain Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0535","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00702-020-02261-4","article-title":"Effects of agmatine, glutamate, arginine, and nitric oxide on executive functions in children with attention deficit hyperactivity disorder","volume":"127","author":"Sari","year":"2020","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00726-020-02928-y","article-title":"Serum amino acid profiles in patients with mild cognitive impairment and in patients with mild dementia or moderate dementia","volume":"53","author":"Socha","year":"2021","journal-title":"Amino Acids"},{"issue":"12","key":"10.1016\/j.ymgme.2026.110205_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05654","article-title":"Nitric oxide role in anxiety-like behavior, memory and cognitive impairments in animal model of chronic migraine","volume":"6","author":"Taheri","year":"2020","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0550","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijdevneu.2010.06.008","article-title":"Guanidino compounds inhibit acetylcholinesterase and butyrylcholinesterase activities: effect neuroprotector of vitamins E plus C","volume":"28","author":"Delwing-de Lima","year":"2010","journal-title":"Int. J. Dev. Neurosci."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0555","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative stress and the central nervous system","volume":"360","author":"Salim","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0560","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(94)90273-9","article-title":"Intrahippocampal administration of the NO synthase inhibitorl-NAME prevents working memory deficits in rats exposed to transient cerebral ischemia","volume":"634","author":"Ohno","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2026.110205_bb0565","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"G\u00f6rlach","year":"2015","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0570","doi-asserted-by":"crossref","first-page":"e70159","DOI":"10.1002\/jimd.70159","article-title":"Cluster of severe arginase 1 deficiency in the Comoros: clinical, neuroimaging, and molecular features in 17 patients from Mayotte compared with 10 from Paris","volume":"49","author":"De Bruyne","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0575","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1023\/A:1005624616905","article-title":"Arginase deficiency presenting with cerebral oedema and failure to thrive","volume":"23","author":"Harrington","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0580","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/0972-2327.167701","article-title":"Late onset arginase deficiency presenting with encephalopathy and midbrain hyperintensity","volume":"19","author":"Maramattom","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0585","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s11011-018-0281-8","article-title":"Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia","volume":"33","author":"Yucel","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2026.110205_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.632307","article-title":"Review of multi-modal imaging in urea cycle disorders: the old, the new, the borrowed, and the blue","volume":"12","author":"Sen","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0595","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1552-6569.2012.00739.x","article-title":"Brain MRI and magnetic resonance spectroscopy findings in patients with hyperargininemia","volume":"24","author":"Carvalho","year":"2014","journal-title":"J. Neuroimaging"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0600","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pediatrneurol.2009.07.017","article-title":"Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts","volume":"42","author":"Oldham","year":"2010","journal-title":"Pediatr. Neurol."},{"issue":"S1","key":"10.1016\/j.ymgme.2026.110205_bb0605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10545-009-1137-5","article-title":"Early-onset hyperargininaemia: a severe disorder?","volume":"32","author":"Schiff","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2026.110205_bb0610","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/dmcn.12488","article-title":"Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring","volume":"56","author":"Amayreh","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2026.110205_bb0615","doi-asserted-by":"crossref","DOI":"10.4021\/jmc141w","article-title":"Arginase deficiency presenting as intractable hiccups with severe Hyperammonemia at one month of age","author":"Iijima","year":"2011","journal-title":"J. Med. Cases"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0620","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0387-7604(83)80059-X","article-title":"Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid","volume":"5","author":"Mizutani","year":"1983","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2026.110205_bb0625","series-title":"Argininemia: Report of a New Case and Mechanisms of Orotic Aciduria and Hyperammonemia","first-page":"121","author":"Yoshino","year":"1982"},{"issue":"11","key":"10.1016\/j.ymgme.2026.110205_bb0630","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/pd.1000","article-title":"Prenatal diagnosis for arginase deficiency by second-trimester fetal erythrocyte arginase assay and first-trimester ARG1 mutation analysis","volume":"24","author":"Korman","year":"2004","journal-title":"Prenat. Diagn."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0635","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.braindev.2019.09.002","article-title":"Sodium phenylbutyrate improved the clinical state in an adult patient with arginase 1 deficiency","volume":"42","author":"Matsufuji","year":"2020","journal-title":"Brain Dev."},{"issue":"21","key":"10.1016\/j.ymgme.2026.110205_bb0640","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1212\/01.wnl.0000304084.59964.e2","article-title":"Diffusion tensor imaging of the pyramidal tracts in infants with motor dysfunction","volume":"71","author":"Ludeman","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0645","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02171562","article-title":"A new case of hyperargininaemia: neurological and biochemical findings prior to and during dietary treatment","volume":"149","author":"Brockstedt","year":"1990","journal-title":"Eur. J. Pediatr."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110205_bb0650","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.21037\/tp-21-112","article-title":"Neurophysiological characteristics in argininemia: a case report","volume":"10","author":"Cui","year":"2021","journal-title":"Transl. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0655","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymgme.2026.110205_bb0660","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting remyelination: towards a consensus on the regeneration of CNS myelin","volume":"116","author":"Franklin","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0665","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110205_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27093785","article-title":"Extracellular vesicles delivered a functional ARG1 enzyme and restored its activity in a mouse model of ARG1-D resulting in improved lifespan","volume":"27","author":"Hsieh","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110205_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2026.04.045","article-title":"A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: a 100-fold dose reduction compared to AAV alone","author":"Xu","year":"2026","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0680","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ymgme.2013.09.003","article-title":"Dietary management of urea cycle disorders: European practice","volume":"110","author":"Adam","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0685","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/jimd.12415","article-title":"Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan","volume":"44","author":"Kido","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110205_bb0690","first-page":"101042","article-title":"Plasma arginine levels in arginase deficiency in the \u2018real world\u2019","volume":"38","author":"Tanpaiboon","year":"2024","journal-title":"Mol. Genet Metab Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0695","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01800000","article-title":"Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet","volume":"5","author":"Cederbaum","year":"1982","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0700","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3476(05)82161-4","article-title":"Hyperargininemia: intellectual and motor improvement related to changes in biochemical data","volume":"118","author":"Lambert","year":"1991","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0705","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3476(79)80082-7","article-title":"Argininemia treated from birth","volume":"95","author":"Snyderman","year":"1979","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0710","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3476(77)80367-3","article-title":"Argininemia","volume":"90","author":"Snyderman","year":"1977","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0715","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70066","article-title":"Long-term efficacy and tolerability of Pegzilarginase in arginase 1 deficiency: results of two international multicentre open-label extension studies","volume":"48","author":"McNutt","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0720","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.pediatrneurol.2014.05.029","article-title":"Hyperargininemia: 7-month follow-up under sodium benzoate therapy in an Italian child presenting progressive spastic Paraparesis, cognitive decline, and novel mutation in ARG1 gene","volume":"51","author":"Baranello","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0725","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-3476(86)80891-5","article-title":"Arginase deficiency in a 12-year-old boy with mild impairment of intellectual function","volume":"108","author":"Bernar","year":"1986","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110205_bb0730","first-page":"218","article-title":"Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis","volume":"24","author":"Braga","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0735","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/BF00711531","article-title":"Arginase deficiency in two brothers","volume":"16","author":"Candito","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"issue":"32","key":"10.1016\/j.ymgme.2026.110205_bb0740","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021634","article-title":"A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia","volume":"99","author":"Cui","year":"2020","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110205_bb0745","doi-asserted-by":"crossref","first-page":"495","DOI":"10.21037\/tp-21-576","article-title":"The effect of liver transplantation for argininemia\u2014the largest experiences in a single center","volume":"11","author":"Cui","year":"2022","journal-title":"Transl. Pediatr."},{"issue":"S1","key":"10.1016\/j.ymgme.2026.110205_bb0750","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10545-009-1148-2","article-title":"Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening","volume":"32","author":"Edwards","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"S3","key":"10.1016\/j.ymgme.2026.110205_bb0755","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10545-010-9263-7","article-title":"Neonatal cholestasis: an uncommon presentation of hyperargininemia","volume":"33","author":"Gomes Martins","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0760","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-3476(83)80481-8","article-title":"Hyperargininemia: effect of ornithine and lysine supplementation","volume":"103","author":"Kang","year":"1983","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110205_bb0765","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ajmg.a.62199","article-title":"Variants associated with urea cycle disorders in Japanese patients: Nationwide study and literature review","volume":"185","author":"Kido","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110205_bb0770","article-title":"Arginase deficiency with parotid gland swelling and hyperamylasemia: a case report","volume":"11","author":"Kuyama","year":"2023","journal-title":"SAGE Open Med. Case Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0775","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2010.11.003","article-title":"Argininemia presenting with progressive spastic Diplegia","volume":"44","author":"Lee","year":"2011","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110205_bb0780","first-page":"434","article-title":"Arginase deficiency masked by cerebral palsy and coagulopathy\u2014three varied presentations of <scp>Latin American<\/scp> origin","volume":"64","author":"Mills","year":"2023","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0785","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1620\/tjem.151.301","article-title":"Enzyme replacement therapy in a patient with hyperargininemia","volume":"151","author":"Mizutani","year":"1987","journal-title":"Tohoku J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0790","first-page":"5","article-title":"Ammonia metabolism in a family affected by hyperargininemia","volume":"7","author":"Qureshi","year":"1981","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0795","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1620\/tjem.142.239","article-title":"A successful trial of enzyme replacement therapy in a case of argininemia","volume":"142","author":"Sakiyama","year":"1984","journal-title":"Tohoku J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0800","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00711380","article-title":"Hyperargininaemia: follow-up of a new case","volume":"18","author":"Scarpa","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110205_bb0805","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.91.5.995","article-title":"Arginase deficiency presenting as cerebral palsy","volume":"91","author":"Scheuerle","year":"1993","journal-title":"Pediatrics"},{"issue":"S2","key":"10.1016\/j.ymgme.2026.110205_bb0810","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10545-008-0903-0","article-title":"Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency","volume":"31","author":"Scholl-B\u00fcrgi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110205_bb0815","series-title":"Liver Transplantation Prevents Progressive Neurological Impairment in Argininemia","first-page":"25","author":"Silva","year":"2013"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110205_bb0820","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4274\/tnd.2020.97752","article-title":"A rare cause of spasticity and microcephaly: Argininemia","volume":"26","author":"Soylu \u00dcstkoyuncu","year":"2020","journal-title":"Turkish J. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110205_bb0825","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41439-021-00139-9","article-title":"Novel ARG1 variants identified in a patient with arginase 1 deficiency","volume":"8","author":"Yokoi","year":"2021","journal-title":"Hum Genome Var."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:39:14Z","timestamp":1790368754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":165,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226004889"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110205","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between elevated arginine and pathophysiology of progressive disease in arginase 1 deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Immedica Pharma AB. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110205"}}